ftInvstr

MANKIND · Healthcare ₹2327.1 -1.31% Mkt Cap ₹96646 Cr fair

MANKIND

Healthcare Drug Manufacturers - Specialty & Generic

★ Watchlist ⧉ Add to bucket

₹2327.1

-1.31% today · 30d -4.08%

as of 2026-09-04

Price · Daily Candles

Detect candlestick pattern

AI narrative is temporarily unavailable for MANKIND. The deterministic sections below render from live data.

₹ Latest Earnings · Q ending 2026-06-30

REVENUE

₹4031 Cr

+12.89% YoY

NET PROFIT

₹574 Cr

+29.12% YoY

OPM

27.02%

+1.63pp YoY

EPS

₹13.76

PE 46.97

Intrinsic value · DCF ₹2869.65 · Margin of safety +23.3% (fair) · FCF yield 2.58%

◇ Sector Position

PEERPEROCE %

MANKIND46.9714.0

SUNPHARMA37.5721.44

DIVISLAB89.1821.56

ZYDUSLIFE24.6424.22

+ 2 more peers — sign in to view

ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

SCORE / 100

Overall

6-axis composite of the sections below.

Performance NEUTRAL 40

Valuation FAIR 40

Growth STEADY 65

Profitability HIGH 75

Technicals WEAK 38

Risk LOW 90

Key Stats

TTM PE

46.97

P/B

5.87

52W HIGH

₹2674.0

OFF HIGH

-12.97%

DIV YIELD

0.08%

MKT CAP

₹96646 Cr

◉ Active Signals

MACDBearish-1.4573

RSI(14)Bearish36.11

Street Consensus

19 analysts

₹2741.74

mean target

Low ₹2057.0Now ₹2327.1High ₹3220.0

⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold MANKIND and at what entry.